Current and Future Treatments of Pancreatic Cancer

Authors

  • Ziyu Han
  • Qianyuan Luo
  • Ran Zhuang

DOI:

https://doi.org/10.54097/ma0fcw58

Keywords:

Pancreatic cancer, pancreas, therapy, development, drawback.

Abstract

Pancreatic cancer (PC) is among the most common tumors in the world. Its incidence rate increases with age. More than half of all pancreatic cancer deaths occur in developed regions. The overall prognosis of pancreatic cancer is pretty bad. Only less than 15% of patients can be treated with surgery, and less than 10% of patients are alive after 5 years. The main purpose of the study is to summarize the current and future expectative treatments for pancreatic cancer. To illustrate it more particularly, we also add the basic introduction of pancreatic cancer, including: types of pancreatic cancer, risk factors of pancreatic cancer, symptoms, treatments, new trend, and the problem existing in the modern treatment. Our objective is to let people see and understand the pancreatic cancer clearer and more systematically. The way we study it is by searching information from the internet, picking the most important part, and putting them distinctly. By summarizing the relevant information, the treatments of pancreatic cancer could be improved.

Downloads

Download data is not yet available.

References

Pancreatic Cancer Risk Factors, n.d.

Brown, T. J., Reiss, K. A., & O'Hara, M. H. (2023). Advancements in Systemic Therapy for Pancreatic Cancer. 43.

Gad, E. H. (2023). Pancreatic Cancer: Updates in Pathogenesis and Therapies.

Albu, A., Gheban, D., Grad, C., & Dumitrascu, D. L. (2012, March 28). Coagulation Disorders in Pancreatic Cancer.

Hamilton, H. H. & Greendyke, R. B. (1991). Calculation of convective and radiative heating on the forebody heatshield of the aeroassist flight experiment vehicle.

Cleveland clinic. (2023, March 17). Pancreatic Cancer: What Is It, Symptoms, Causes & Treatment. Cleveland Clinic.

Schmidt-Hansen M, Berendse S, Hamilton W. (2016). Symptoms of pancreatic cancer in primary care: A systematic review. 45 (6): 814 - 818.

Esmail, A., Badheeb, M., & Abdelrahim, M. (2023). Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening.

Utsunomiya J, Gocho H, Miyanaga T, Hamaguchi E, Kashimure A. (1975). Peutz-Jeghers syndrome: Its natural course and management. 136 (2): 71 - 82.

Lucas AL, Kastrinos F. (2019 Aug 6). Screening for Pancreatic Cancer.

Henrikson NB, Bowles EJA, Blasi PR, Morrison CC, Nguyen M, Pillarisetty VG, et al. (2019). Screening for pancreatic cancer: Updated evidence report and systematic review for the US preventive services task force.

Pancreatic Cancer Finds Alternate Fuel for Survival, Growth - NCI. (2023, June 22).

Ben-Ari, E. (2023, January 12). MRTX1133 Targets Tumors with KRAS G12D Mutations - NCI.

Targeting Abnormal Collagen to Treat Pancreatic Cancer - NCI. (2022, August 22).

Downloads

Published

29-12-2023

How to Cite

Han, Z., Luo, Q., & Zhuang, R. (2023). Current and Future Treatments of Pancreatic Cancer. Highlights in Science, Engineering and Technology, 74, 1769-1773. https://doi.org/10.54097/ma0fcw58